Monday, November 14, 2011

China Kangtai Cactus Biotech Worthy To Look At?

China Kangtai Cactus Biotech Q3 Revenue Up 39% to $13.3M; Q3 Operating Income Up 72% to $5.38M; EPS $0.18; Net Income Up 42% to $4M. YTD Revenue Up 23% to $29.2M; Operating Income Up 71% to $11.26M

Press Release

Or course you never know for sure a company is legitimate! The fact that Hawk Associates is still representing the company and most information is public available a little bet can be yours.

The company earns more than their current stock price shows, but here also the risk of GOING DARK!

1 comment: